ACUTE RENAL FAILURE

Download Report

Transcript ACUTE RENAL FAILURE

ACUTE RENAL FAILURE
INTERN EMERGENCY
LECTURE SERIES 2005
DEFINITION
ABRUPT DECREASE IN RENAL
FUNCTION RESULTING IN THE
ACCUMULATION OF
NITROGENOUS COMPOUNDS
SUCH AS UREA AND
CREATININE
A
Acute vs Chronic Renal
Failure

History
» Known Chronic
» Recent Toxic Exposure
» Recent Hypoxic Insult
» Recent Trauma
» Known Diseases Associated with ARF
» Prev. Abnormal Lab Results Suggesting
Chronic
Acute vs Chronic Renal
Failure
Rapidly Rising Creatinine = Acute
 Kidney Size

» Small = Chronic

Renal Ultrasound
» Increased Echogenicity = Chronic

Urine Flow Rate
» Oliguric or Anuric usually = Acute
ACUTE RENAL FAILURE
CLASSIFICATION BY URINE
VOLUME
OLIGURIC: <400 CC/ 24 Hrs
NON-OLIGURIC: >500 CC/24 Hrs
ANURIC
<50 CC/24 Hrs
ETIOLOGY OF ACUTE RENAL
FAILURE

PRE-RENAL
55-60%

POST RENAL
<5%

RENAL
35-40%
PRE-RENAL ACUTE RENAL
FAILURE

MOST COMMON CAUSE OF ARF

RESULTS FROM DECREASED RENAL
PERFUSION

TREATMENT OF THE CAUSE RESTORES
RENAL FUNCTION TUBULAR FUNCTION
INTACT *

PROLONGED PRE-RENAL FAILURE MAY
LEAD TO ATN
CAUSES OF PRE-RENAL
AZOTEMIA
Intravascular volume depletion
 Decreased cardiac output
 Systemic vasodilation

» Antihypertensives
» Sepsis
Renal vasoconstriction
 Drugs impairing autoregulation

» Ace inhibitors
NSAID
MECHANISMIS OF PRE
RENAL ARF
POST-RENAL ACUTE RENAL
FAILURE
ACCOUNTS FOR 2-15% OF ALL ARF
 OBSTRUCTION TO URINE FLOW

» INCREASED TUBULAR PRESSURE
» VASOCONSTRICTION
– DECREASED RENAL BLOOD FLOW

MUST BE BILATERAL TO RESULT IN
ARF
» UNLESS : SINGLE KIDNEY OR PRIOR
CHRONIC RENAL FAILURE
POST RENAL ACUTE RENAL
FAILURE
SUSPECT OBSTRUCTION IN ANURIA
 ETIOLOGY MAY BE AGE
DEPENDENT

» YOUNG = CONGENITAL ABNORMALITY
» OLDER MALE = PROSTATIC
ENLARGEMENT

ARF MOST OFTEN ASSOCIATED
WITH LESIONS IN:
» BLADDER, PROSTATE OR URETHRA
RENAL-ACUTE RENAL FAILURE

VASCULAR DISEASE
» VASCULITIS (SLE, POLYARTERITIS
ETC.)
» SCLERODERMA
» THROMBOEMBOLIC DISEASE
» MALIGNANT HYPERTENSION
RENAL--ACUTE RENAL
FAILURE

GLOMERULAR DISEASE
» ACUTE GLOMERULONEPHRITIS
–POST INFECTIOUS GN
–CRESCENTIC GN

ANCA POSITIVE DISEASES
–GOODPASTURE’S DIS.

ANTI- GLOMERULAR BASEMENT
ANTIBODY
RBC CAST
ACUTE INTERSTITIAL NEPHRITIS
DRUG INDUCED





PENICILLINS
SULFONAMIDES
CEPHALOSPORIN
RIFAMPIN ( 2ND
TIME)
QUINOLONES






NSAID
(FENOPROFEN)
ALLOPURINOL
PHENYTOIN
THIAZIDES
FUROSEMIDE
CIMETIDINE
Acute Interstitial Nephritis
 Fever
 Rash
 Eosinophilia
 Pyuria
 Eosinophiluria
 WBC
Casts
WBC Cast
RENAL --ACUTE RENAL FAILURE

ACUTE TUBULAR NECROSIS
» ISCHEMIC INJURY
» TOXIC INJURY
– ENDOGENOUS TOXINS

HEMOGLOBINURIA

MYOBLOBINURIA (RHABDOMYOLYSIS)

ENDOTOXEMIA
RENAL-- ACUTE RENAL FAILURE

ACUTE TUBULAR NECROSIS
» EXOGENOUS TOXINS
– AMINOGLYCOSIDES
– RADIOGRAPHIC CONTRAST
– HEAVY METAL COMPOUNDS
– ETHYLENE GLYCOL
– METHANOL
– CARBON TETRACHLORIDE
– CIS PLATIN
HIGH RISK SETTINGS FOR ATN
CLINICAL SETTING
FREQUENCY







GEN.MED. --SURG.
INTENSIVE CARE
OPEN HEART SURG
AMINOGLYCOSIDE
BURNS
RHABDOMYOLYSIS
CIS-PLATIN
3-5%
5-25%
5-20%
10-30%
20-60%
20-30%
15-25%
ATN SEDIMENT
DIAGNOSTIC APPROACH TO ARF
HISTORY
 PHYSICAL EXAMINATION
 ASSMENT OF URINE VOLUME
 URINE ANALYSIS
 BLOOD CHEMISTRY
 BLOOD AND URINE INDICES
 RADIOLOGIC STUDIES

Treatment of ARF
Hyperkalemia
Never occurs in the absence of renal
excretory problem
 Pseudohyperkalemia

» Leukocytosis
» Thrombocytosis
» Prolonged Application of Tourniquet
Hyperkalemia
Significance of urine output
 Role of increased catabolism or tissue
breakdown
 Factors affecting shift of Potassium out
of cells
 Etiololgy of the renal failure

Treatment of Hyperkalemia
Urgency
 Role of the EKG in making the decision
 Clinical setting in which it occurs

» Acute renal failure
» Chronic renal failure
Table 5-3. Treatment of hyperkalemia
Medication
Mechanism of action
Dosage
Calcium
gluconate
Antagonism of
membrane
Insulin and
Glucose
Increased K+entry
into the cells
Insulin, 10 U IV bolus
followed by 0.5 mU/kg of
body weight per minute in
50 ml of 20% glucose
Sodium
bicarbonate
Increased K+entry
into the cells
44-50 mEq IV over 5 min;
can be repeated within 30
min
Albuterol
Increased K+entry
into the cells
10-30 ml of 10% solution IV
over 2 min
Peak effect
-5 min
30-60 min
30-60 min
20 mg in the nebulized form
30-60 min
Kayexalate
Removal of the
excess K+
20 g of resin with 100 ml of
20% sorbitol; can be
repeated every 4-6 hr
2-4 hr
Hemodialysis
Removal of the
excess K+
Dialysis bath K+ concentration
variable
30-60 min
INDICATIONS FOR DIALYSIS IN
ACUTE RENAL FAILURE
UREMIC SYMPTOMS
~ nausea
~ neurologic
 SEVERE FLUID OVERLOAD
 REFRACTORY ELECTROLYTE
DISORDERS
~hyperkalemia
 SEVERE REFRACTORY ACIDOSIS

INDICATIONS FOR DIALYSIS IN
ACUTE RENAL FAILURE
PERICARDITIS
 NEUROPATHY
 MENTAL STATUS CHANGE
 SEIZURES
 BLEEDING
 TOXINS----ETHYLENE GLYCOL,

METHANOL

PROPHYLACTIC
~recent studies fail to document benefit
MORTALITY ASSOCIATED WITH
SETTING OF ATN
OVERALL MORTALITY
40-60%
 POST TRAUMATIC
70-90%
 MEDICAL CAUSE
15-40%
 SURGICAL CAUSE
40-80%
 NON-OLIGURIC
26% *
 OLIGURIC
50% *

CAUSES OF DEATH IN ATN